The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has unveiled a new business plan to build on the launch of a three-year corporate plan. The new plan will build on the 2023 ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (3 June 2026) authorised the medicine resmetirom (Rezdiffra) to treat adult ...

Launched today by the Medicines and Healthcare products Regulatory Agency (the MHRA), the seventh annual #MedSafetyWeek is running until 13 November to encourage widespread public engagement and ...

UK MHRA grants marketing approval to Madrigal Pharmaceuticals’ resmetirom to treat metabolic dysfunction-associated steatohepatitis in adults: United Kingdom Friday, June 5, 202 ...

Proposed changes may better align the system with international standards, though continued divergence between the UK and EU regulatory landscapes ...

The UK’s medicines regulator has set out plans to accelerate the development and approval of treatments for rare diseases ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teprotumumab (Tepezza, Amgen) as the first treatment to be licensed in the UK for adults with moderate-to-severe thyroid eye ...

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has launched a refreshed Innovative Licensing and Access Pathway (ILAP) to accelerate patient access to new medicines by integrating ...

The Medicines and Healthcare Products Regulatory Agency are a national oversight body who oversee the safe and appropriate use of medicinal products and medical devices in the UK. This includes ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has shared guidance on how extreme heat such as that the UK is ...